Community hospital oversight of clinical investigators' financial relationships

IRB Ethics and Human Research

Volumn 31, Issue 1, 2009, Pages 7-13

  Hall, Mark A ^a   Weinfurt, Kevin P ^b   Lawlor, Janice S ^c   Friedman, Joëlle Y ^b   Schulman, Kevin A ^b   Sugarman, Jeremy ^d  

^a WAKE FOREST UNIVERSITY   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY HOSPITAL; CONFLICT OF INTEREST; ECONOMICS; ETHICS; HUMAN; PERSONNEL; PROFESSIONAL STANDARD; RESEARCH ETHICS; UNITED STATES;

CONFLICT OF INTEREST; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; HOSPITALS, COMMUNITY; HUMANS; RESEARCH PERSONNEL; UNITED STATES;

EID: 60149089006     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Association of American Medical Colleges (AAMC). Task Force on Financial Conflicts of Interest in Clinical Research. Protecting Subjects, Preserving Trust, Promoting Progress-Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research, December 2001;
2. Association of American Universities (AAU). Task Force on Research Accountability. Report on Individual and Institutional Financial Conflict of Interest. October 2001.
3. U.S. Government Accountability Office. HHS Direction Needed to Address Financial Conflicts of Interest, November 2001.
4. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research. JAMA 2003;286(4):454-465;
5. Cho MK et al. Policies on faculty conflicts of interest at U.S. universities. JAMA 2000;284:2203-2208;
6. Korn D. Conflicts of interest in biomedical research. JAMA 2000;284:2234-2237;
7. Lo B, Wolf L, Berkley A. Conflict-of-interest policies for investigators in clinical trials. NEJM 2000;343:1616-1620;
8. McCrary SV et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. NEJM 2000;343(22):1621- 1626;
9. Weinfurt KP et al. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Academic Medicine 2006;81(2):113-118.
10. Boyd EA, Lipton S, Bero LA. Implementation of financial disclosure policies to manage conflicts of interest. Health Affairs 2004;23(2):206-214;
11. Hampson LA et al. Patients' views on financial conflicts of interest in cancer research trials. NEJM 2006;355(22): 2330-2337;
12. Weinfurt KP et al. Disclosing conflicts of interest in clinical research: Views of institutional review boards, conflict of interest committees, and investigators. Journal of Law, Medicine & Ethics 2006;34(3):581-591.
13. Christensen JA, Orlowski JP. Bounty-hunting and finder's fees. IRB: Ethics & Human Research 2005;27(3):16-19;
14. Department of Health and Human Services. Office of Inspector General. Recruiting Human Subjects: Pressures in Industry-Sponsored Clinical Research, 2000.
15. Klein JE, Fleischman AR. The private practicing physician-investigator: Ethical implications of clinical research in the office setting. Hastings Center Report 2002;32(4):22-26;
16. Fleischman AR, Klein JE. Clinical research in the private office setting-ethical issues. Transactions of the American Clinical and Climatological Association 2002;113:126-35;
17. Williams KM. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Food and Drug Law Journal 2004;59(1):45-77;
18. Lader EW et al. The clinician as investigator: Participating in clinical trials in the practice setting. Circulation 2004;109(21):2672-2679.
19. Dinan MA et al. Comparison of conflict of interest policies and reported practices in academic medical centers in the United States. Accountability in Research 2006;13:325-342.
20. See ref. 4, Weinfurt et al. 2006;
21. see ref. 7 Dinan et al. 2006.
22. See ref. 5, Office of Inspector General 2000.
23. Larson E et al. A survey of IRB process in 68 U.S. hospitals. Journal of Nursing Scholarship 2004;36(3):260-264.
24. See ref. 4, Weinfurt et al. 2006.
25. Wolf L, Croughan MP, Lo BM. The challenges of IRB review and human subjects protections in practice-based research. Medical Care 2002;40(6):521-529.
26. See ref. 4, Weinfurt et al. 2006.
27. Lemmens T, Miller PB. The human subjects trade: Ethical and legal issues surrounding recruitment incentives. Journal of Law, Medicine and Ethics 2003;31(3):398.
28. See ref. 5, Office of Inspector General 2000.